Investing Profile

Vineeta Agarwala

VCInvestor

General Partner @a16z; Physician @Stanford

a16z.com/author/vineeta-agarw...San Francisco Bay Area
Photo of Vineeta Agarwala, General Partner at Andreessen Horowitz

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Andreessen Horowitz General Partner
$10K - $100.0M
$10.0M
10
$2.2B
CompanyStageDateRound SizeTotal Raised
Orbital Therapeutics
Seed RoundSep 2022
Co-investors: Kristina Burow (ARCH Venture Partners)
BigHat Biosciences
Series BJul 2022$75M
Series AFeb 2021$19M
$94M
Co-investors: Steve Kafka (Section 32), Andy Harrison (Section 32)
Memora Health
Venture RoundFeb 2022$40M
Venture RoundMay 2021$11M
$54M
Co-investors: Karen Page (B Capital Group), Nat Turner (Operator Partners), Adam Grosser (UP.Partners), Rich Kleiman (Thirty Five Ventures), Kevin Durant (Thirty Five Ventures), Brenton Fargnoli (AlleyCorp), Zach Weinberg (Curie.Bio), Joshua Schachter, Moshe Lifschitz
Waymark
Series AJan 2022$45M
$47M
Co-investors: Mohamad Makhzoumi (New Enterprise Associates (NEA)), Gabe Karp (Lightbank)
Thyme Care
Series AOct 2021$22M
$22M
Co-investors: Brenton Fargnoli (AlleyCorp), Vivek Garipalli
Pearl Health
Series ASep 2021$18M
$74M
Co-investors: Scott Kupor (Andreessen Horowitz), Jordan Wan (CoFound Partners)
Bayesian Health
Venture RoundJul 2021$15M
$15M
Co-investors: Vijay Pande (Andreessen Horowitz), Julie Yoo (Andreessen Horowitz), R. Jacob Vogelstein (Catalio Capital)
IDEAYA Biosciences
Series BMar 2018$94M
$140M
Co-investors: Tim Shannon (Canaan Partners), Thilo Schroeder (Nextech Invest)
therapeutics, diagnostics, and digital health, with a focus on companies that are leveraging unique datasets to improve drug development and patient care delivery